Blueprint Medicines - Funding, Financials, Valuation, Investors - Cointime

Bitcoin $83,668.52 +0.22%
Ethereum $2,682.21 +0.10%
BNB $767.23 +1.44%
Optimism $0.13 -0.66%
Arbitrum $0.20 -1.37%
Solana $118.03 -0.52%
Polygon $0.22 +2.77%
Cosmos $1.73 +0.23%
Avalanche $10.93 -4.29%

Bitcoin $83,668.52 +0.22%
Ethereum $2,682.21 +0.10%
BNB $767.23 +1.44%
Optimism $0.13 -0.66%
Arbitrum $0.20 -1.37%
Solana $118.03 -0.52%
Polygon $0.22 +2.77%
Cosmos $1.73 +0.23%
Avalanche $10.93 -4.29%

Blueprint Medicines

company

Investors

Number of Lead Investors

Number of Investors

4

15

Blueprint Medicines is funded by 15 investors. Partner Fund Management and Eight Roads Ventures are the most recent investors.

Investor Name	Lead Investor	Funding Round
Partner Fund Management	Yes	Series C
Eight Roads Ventures	Yes	Series Unknown
Casdin Capital	-	Series C
Cowen Group	-	Series C
Fidelity Biosciences	-	Series C
Nextech Invest	-	Series C
Perceptive Advisors	-	Series C
RA Capital Management	-	Series C
Redmile Group	-	Series C
Sabby Capital	-	Series C
Tavistock Life Sciences	-	Series C
Third Rock Ventures	-	Series C
Wellington Management	-	Series C
Biotechnology Value Fund	-	Series B
F-Prime Capital	-	Series B